The Orally Administered Selective TRPV1 Antagonist, JTS-653, Attenuates Chronic Pain Refractory to Non-steroidal Anti-inflammatory Drugs in Rats and Mice Including Post-herpetic Pain
Chronic pain refractory to non-steroidal anti-inflammatory drugs (NSAIDs) is a major problem and drugs for such pain are needed. Many studies suggest that transient receptor potential vanilloid type 1 (TRPV1) is associated with NSAID-refractory chronic pain. Therefore, we investigated the involvemen...
Main Authors: | Yoshihiro Kitagawa, Isao Tamai, Yuji Hamada, Kenji Usui, Masashi Wada, Masahiro Sakata, Mutsuyoshi Matsushita |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319303305 |
Similar Items
-
Tolerability, pharmacokinetics, and anti-herpetic activity of orally administered BX795
by: Tejabhiram Yadavalli, et al.
Published: (2023-09-01) -
An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy
by: Zin, Che Suraya, et al.
Published: (2008) -
HIGH-INTENSITY LASER THERAPY TO TREAT NEUROPATHIC PAIN IN POST-HERPETIC NEURALGIA
by: Richard Suherlim, et al.
Published: (2022-12-01) -
Pharmacological Differences Between Static and Dynamic Allodynia in Mice With Herpetic or Postherpetic Pain
by: Atsushi Sasaki, et al.
Published: (2008-01-01) -
TRPV4 Role in Neuropathic Pain Mechanisms in Rodents
by: Patrícia Rodrigues, et al.
Published: (2022-12-01)